Identification of ALK Mutation in Neuroblastoma on the Point of Molecular Heterogeneity

BACKGROUND AND AIM: In neuroblastoma, anaplastic lymphoma kinase mutations have recently received attention as molecular targets for the treatment of neuroblastoma, as 6% to 10% of patients with neuroblastoma have anaplastic lymphoma kinase mutations. There are little data from the cases in Turkey....

Descripción completa

Detalles Bibliográficos
Autores principales: Aktaş, Tekincan Çağrı, Kızmazoğlu, Deniz, Aktaş, Safiye, Gökbayrak, Özde Elif, Serinan, Efe, Erol, Aylin, Altun, Zekiye, Yuan, Hongling, Olgun, Hatice Nur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Tumor Heterogeneity: New Mechanisms and Therapeutic Possibilities
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652808/
https://www.ncbi.nlm.nih.gov/pubmed/37964559
http://dx.doi.org/10.1177/15330338231211138

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10652808/
https://www.ncbi.nlm.nih.gov/pubmed/37964559
http://dx.doi.org/10.1177/15330338231211138

Ejemplares similares